ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Re: Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer
The Journal of Urology
◽
10.1097/01.ju.0000554055.35801.21
◽
2019
◽
Vol 201
(5)
◽
pp. 857-858
Author(s):
Sam S. Chang
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Preclinical Evaluation
◽
Muscle Invasive
Download Full-text
Related Documents
Cited By
References
Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non–Muscle-Invasive Bladder Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-17-1082
◽
2017
◽
Vol 23
(21)
◽
pp. 6592-6601
◽
Cited By ~ 22
Author(s):
Max Kates
◽
Abhijit Date
◽
Takahiro Yoshida
◽
Umara Afzal
◽
Pranjali Kanvinde
◽
...
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Preclinical Evaluation
◽
Muscle Invasive
Download Full-text
Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer
Drug Delivery and Translational Research
◽
10.1007/s13346-020-00870-w
◽
2020
◽
Author(s):
Abhijit A. Date
◽
Max Kates
◽
Takahiro Yoshida
◽
Taarika Babu
◽
Umara Afzal
◽
...
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Preclinical Evaluation
◽
Intravesical Treatment
◽
Muscle Invasive
Download Full-text
Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer
Urology
◽
10.1016/j.urology.2020.06.087
◽
2020
◽
Cited By ~ 1
Author(s):
Jessica Marinaro
◽
Alexander Zeymo
◽
Jillian Egan
◽
Filipe Carvalho
◽
Ross Krasnow
◽
...
Keyword(s):
Bladder Cancer
◽
Racial Disparities
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer
Urologic Oncology Seminars and Original Investigations
◽
10.1016/j.urolonc.2020.11.017
◽
2020
◽
Author(s):
Xuan-Mei Piao
◽
Ho Won Kang
◽
Pildu Jeong
◽
Young Joon Byun
◽
Hee Youn Lee
◽
...
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
339: Selective Bladder Preservation by Transurethral Layer-Section in T2 Muscle-Invasive Bladder Cancer
The Journal of Urology
◽
10.1016/s0022-5347(18)30604-9
◽
2007
◽
Vol 177
(4S)
◽
pp. 114-115
Author(s):
Young Deuk Choi
◽
Kang Su Cho
◽
Soung Yong Cho
◽
Hyun Min Choi
◽
Nam Hoon Cho
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Bladder Preservation
◽
Muscle Invasive
Download Full-text
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
Case Medical Research
◽
10.31525/ct1-nct03844256
◽
2000
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
Mitomycin C
◽
Invasive Bladder Cancer
◽
Curative Treatment
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
◽
Bladder Sparing
Download Full-text
Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer
Case Medical Research
◽
10.31525/ct1-nct03950362
◽
2019
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Bladder Preservation
◽
Muscle Invasive
Download Full-text
Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy
Case Medical Research
◽
10.31525/ct1-nct03993249
◽
2019
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
Case Medical Research
◽
10.31525/ct1-nct04040725
◽
2019
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
High Risk
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Muscle Invasive
Download Full-text
TRIO Bladder: A Phase Ib Study of Durvalumab (MEDI 4736) Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation, Based on Molecular Subtypes in Muscle-Invasive Bladder Cancer
Case Medical Research
◽
10.31525/ct1-nct04073160
◽
2019
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
Molecular Subtypes
◽
Invasive Bladder Cancer
◽
Muscle Invasive Bladder Cancer
◽
Phase Ib
◽
Muscle Invasive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close